CLINICAL_TRIALS
trial_result
· 2025-12-12
Clinical Trial Update: MEXIDOL® Sequential Therapy of Patients With Primary Open-angle Glaucoma (POAG) [Phase 4]
Summary
Phase 4 clinical trial evaluating sequential therapy with MEXIDOL in patients with primary open-angle glaucoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pharmasoft | Conditions: Primary Open-Angle Glaucoma (POAG) | Phase 4 | Status: COMPLETED